Cytokinetics (CYTK) Revenue (2010 - 2026)
Cytokinetics (CYTK) reported Revenue of $28.62 million for Q2 2026, down 57.1% from $66.77 million a year earlier but up 47.9% from the prior quarter.
Cytokinetics (CYTK) Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cytokinetics' Revenue came in at $67.67 million, down 19.3% year-over-year; for FY2025, it was $88.04 million, up 486.9% from FY2024.
- Revenue has a five-year compound annual growth rate of 9.5% (FY2020 to FY2025).
- By year, Revenue came in at $15 million in FY2024 (+99.2%), $7.53 million in FY2023 (-92.0%), $94.59 million in FY2022 (+34.3%) and $70.43 million in FY2021 (+26.2%).
- Five-year quarterly Revenue spans a low of $249,000 in Q2 2024 and a high of $88.97 million in Q2 2022.
- Year over year, Revenue gained in five of the last six quarters, with growth averaging 198.0%.
- The high point for year-over-year Revenue in five years was Q4 2024 (growth of 797.1%); the low point was Q2 2023 (a decline of 99.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $19.36 million (Q1 2026), $17.76 million (Q4 2025) and $1.94 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Cytokinetics | 9.20 Bn | 5.37 Bn | 25.89 Mn | 28.62 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.62 Mn |
| Mar 31, 2026 | 19.36 Mn |
| Dec 31, 2025 | 17.76 Mn |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 66.77 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 15.00 Mn |
| Sep 30, 2024 | 463,000.00 |
| Jun 30, 2024 | 249,000.00 |
| Mar 31, 2024 | 835,000.00 |
| Dec 31, 2023 | 1.67 Mn |
| Sep 30, 2023 | 378,000.00 |
| Jun 30, 2023 | 867,000.00 |
| Mar 31, 2023 | 4.61 Mn |
| Dec 31, 2022 | 1.96 Mn |
| Sep 30, 2022 | 2.52 Mn |
| Jun 30, 2022 | 88.97 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 55.60 Mn |
| Sep 30, 2021 | 5.44 Mn |
Cytokinetics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=CYTK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();